Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $64.75
• Market Cap: $4.70B
• EPS: $-3.66
• 52-Week High: $94.90
• 52-Week Low: $13.22

Market Sentiment

Structure Therapeutics Inc. American Depositary Shares currently has a Neutral sentiment score of 0.12.

About Structure Therapeutics Inc. American Depositary Shares

Structure Therapeutics Inc. (GPCR) is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative oral therapeutics for chronic diseases with substantial unmet medical needs. The company boasts a promising pipeline of drug candidates, leveraging advanced scientific methodologies and a robust patient-centric focus to create effective treatment solutions. With its commitment to improving patient outcomes, Structure Therapeutics is well...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Structure Therapeutics Inc. American Depositary Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GPCR pay dividends?

Structure Therapeutics Inc. American Depositary Shares (GPCR) does not currently pay a regular dividend.

What is GPCR's market cap?

Structure Therapeutics Inc. American Depositary Shares (GPCR) has a market capitalization of $4.70B with a current stock price of $64.75.